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Abstract
Background—Type 2 helper T (Th2) cells have long been believed to play a pivotal role in 
allergic immune responses, including IgE antibody production and type 2 cytokine-mediated 
inflammation and pathology. A new T cell subset, T follicular helper cells (Tfh) cells, is 
specialized in supporting B cell maturation and antibody production.
Objective—To investigate the roles of Tfh cells in allergic immune responses.
Methods—Naïve mice were exposed to cytokines or natural allergens through the airways. 
Development of allergic immune responses was analyzed by collecting draining lymph nodes 
(LNs) and sera and by challenging the animals. Cytokine reporter mice and gene-deficient mice 
were used to dissect the immunologic mechanisms.
Results—We observed the development of IL-4-producing Tfh cells and Th2 cells in draining 
LNs following airway exposure to IL-1 family cytokines or natural allergens. Tfh cells and Th2 
cells demonstrated unique phenotypes, tissue localization, and cytokine responses. Tfh cells 
supported the sustained production of IgE antibody in vivo in the absence of other T cell subsets or 
even when Th2 cell functions were severely compromised. Conversely, conditional deficiency of 
the master regulator Bcl6 in CD4+ T cells resulted in a marked reduction in Tfh cells and IgE 
antibody levels, but type 2 cytokine responses and eosinophilic inflammation in the airways 
remained unaffected.
Conclusion—Tfh cells play critical roles in the regulation of IgE antibody production. Allergic 
immune responses to airborne allergens likely involve two distinct subsets of IL-4-producing 
CD4+ T cells, namely Tfh cells and Th2 cells.
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INTRODUCTION
Type 2 immune responses to allergens and other environmental factors, including type 2 
helper T (Th2) cell cytokine responses and the production of IgE antibodies, are key 
immunologic features of allergic diseases. Th2-type CD4+ T cells and type 2 innate 
lymphoid cells (ILC2s) that produce interleukin (IL)-4, IL-5, and IL-13 have been 
considered major players in directing the pathophysiology of allergic disease, including 
airway eosinophilia, mucosal hyperplasia, and airway remodeling.1, 2 However, our 
knowledge regarding the immunological mechanisms that regulate IgE antibody production 
is limited. Traditionally, Th2 cells are expected to play a critical role3 because they produce 
IL-4, a key cytokine that regulates IgE class switching.4
Considerable heterogeneity exists in the clinical phenotypes and genetic contributions to 
allergic diseases. For example, not all patients with asthma develop IgE antibodies to 
allergens, and not all patients with detectable serum IgE antibody levels develop asthma.5, 6 
A genome-wide association study (GWAS) identified a link between asthma/airway 
eosinophilia and single nucleotide polymorphisms (SNPs) in IL1RL1, IL18R, IL33, TSLP, 
and RORA.7 In contrast, associations between serum IgE levels and SNPs in FCER1A, 
IL13, STAT6, and IL4R/IL21R were identified, but very few genes commonly associated 
with both serum IgE level and asthma.7 Thus, the fundamental question of whether Th2-type 
cytokine responses and IgE antibody production are regulated by the same immunological 
pathway remains unanswered.
T follicular helper (Tfh) cells are distinguished from other CD4+ Th cells by their selective 
role in orchestrating germinal center (GC) responses and in promoting the development of 
memory B cells and long-lived plasma cells.8, 9 In mice immunized systemically by 
intraperitoneal injection of ovalbumin (OVA) plus alum adjuvant, a positive correction 
between the development of IL-4-secreting Tfh cells and the production of IgE and IgG1 
antibodies was observed.10 Further, IL-4-secreting Tfh cells mediated class switching and 
affinity maturation of IgE and IgG1 in the lymph nodes of mice infected with the parasites 
Leishmania major and Nippostrongylus brasiliensis.11 Other studies involving Schistosoma 
mansoni and Heligmosomoides polygyrus also demonstrated the production of IL-4 by Tfh 
cells.12, 13 However, information regarding the contribution of Tfh cells to the regulation of 
IgE antibodies in allergic immune responses to airborne allergens remains limited.
Accordingly, to better understand the development of CD4+ T cell subsets in response to 
inhaled allergens and to elucidate their roles in allergic immune responses, we utilized 
mouse models of airway allergen exposure. Our observations suggest a critical role for Tfh 
cells in the regulation of IgE antibody production. Hence, allergic immune responses might 
be mediated by Tfh and Th2 cells, which are two distinct subsets of IL-4-producing CD4+ T 
cells.
MATERIALS AND METHODS
See the Methods section of this article’s Online Repository for more details.
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Mice
BALB/cJ, C.129-Il4tm1Lky/J (4get), C57BL/6J, B6.129P2-Tcrbtm1Mom/J (Tcrb−/−), STOCK 
Tg(Cd4-cre)1Cwi/BfluJ (CD4-Cre), B6.129S7-Il7rtm1Imx/J (Il7r−/−), B6Cr.129S4-
Tnfsf4tm1Sug/Pgn (Tnfsf4−/−), B6.129P2-Icostm1Mak/J (Icos−/−), and B6.129S7-Il1r1tm1lmx/J 
(Il1r1−/ −) mice were obtained from Jackson Laboratories (Bar Harbor, ME). The Bcl6fl/fl 
mice were previously described.14 The procedures and handling of the mice were reviewed 
and approved by the Mayo Institutional Animal Care and Use Committee, Mayo Clinic, 
Rochester, MN.
Antigens, allergens and recombinant cytokines
Endotoxin-free OVA (< 0.5 EU/mg, verified by a Limulus amebocyte lysate assay; Wako 
Chemicals USA, Inc., Richmond, VA) was prepared using specific pathogen-free (SPF) 
chicken eggs (Charles River Laboratories, Wilmington, MA) under sterile conditions as 
previously described.15
Mouse airway exposure and challenge model
On days 0 and 7, naïve mice were lightly anesthetized with tribromoethanol or isoflurane 
and administered 100 μg OVA intranasally (i.n.) in the presence or absence of 100 ng or 
serial dilutions of IL-33 or IL-1β in 50 μl of endotoxin-free PBS. On day 11, the mice were 
euthanized by an overdose of pentobarbital, and mediastinal lymph nodes (mLNs) were 
collected. In some experiments, mice were exposed i.n. to Alternaria (50 μg), cockroach (50 
μg), or HDM (400 μg) extracts, or bromelain (10 μg), or to Alternaria (50 μg) plus OVA (10 
μg). Some mice were then challenged i.n. with 100 μg OVA using the protocols described in 
the figures and figure legends.
Plasma antibody levels
Plasma levels of OVA-specific IgE, IgG1, and IgG2a were measured by ELISA as 
previously described.16 Total IgE, IgG1, IgM, and IgA levels were measured by ELISA in 
accord with recommended protocols using antibodies from BD Biosciences (San Jose, CA).
FACS analyses of mLN cells and lung cells
Anterior and posterior mLNs from each mouse were harvested and pooled. Single cell lung 
suspensions were prepared by digesting harvested lungs using a cocktail of collagenases in 
the presence of DNase as described previously.15 The mLN cells and single cell lung 
suspensions were preincubated with Fc-receptor blockers for 30 min at 4°C and stained with 
combinations of antibodies and analyzed by gating on lymphocytic cells using a 
FACSCalibur™ flow cytometer (BD Biosciences Immunocytometry Systems). See the 
Methods section of this article’s Online Repository for the list of antibodies and details 
regarding analysis strategies.
Gene expression analyses
Day 11 mLN cells from 4get mice exposed to OVA plus IL-33 were enriched for CD4+ T 
cells (Negative Selection Kit, Stemcell Technologies, Vancouver, Canada) and stained as 
described above without fixation. CD4+IL-4eGFP−, CD4+IL-4eGFP+ ST2+CXCR5−, and 
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CD4+IL-4eGFP+ ST2−CXCR5+ populations were sorted using a FACSAria™ flow 
cytometer (BD Biosciences). Cells were lysed in Trizol (Invitrogen, Carlsbad, CA), and total 
RNA was extracted and purified using the PureLink® RNA Mini Kit (Thermo Fisher 
Scientific, Minneapolis, MN) followed by microarray and qRT-PCR analyses.
Cytokine production in vitro
Day 11 mLN cells were isolated, washed, and cultured in RPMI 1640 medium with 10% 
calf serum, 100 μg/ml streptomycin, and 100 U/ml penicillin (complete RPMI) at a density 
of 4 x 105 cells/200 μl/well in a round-bottom 96-well tissue culture plate for 4 days. OVA 
was added at a concentration of 100 μg/ml. Alternatively, day 11 mLN cells were enriched 
for CD4+ T cells and sorted for CD3+CD4+ST2−CXCR5−, CD3+CD4+ST2+CXCR5−, and 
CD3+CD4+ST2−CXCR5+ cell populations. B cells were isolated from day 11 mLN cells 
using a magnetic separation kit (Stemcell Technologies). T cells (20,000 cells/well) were 
cultured with B cells (100,000 cells/well) in complete RPMI medium (total volume 200 μl/
well) with 100 μg/ml OVA for 7 days.
Adoptive transfer
CD3+CD4+ST2−CXCR5−, CD3+CD4+ST2+CXCR5−, and CD3+CD4+ST2−CXCR5+ cell 
populations from the donor C57BL/6 mice were sorted as described above. The recipient 
Tcrb−/ − mice were administered OVA plus IL-33 i.n. on days 0 and 7, and injected with 
75,000 sorted cells intravenously (i.v.) 1 day after the first exposure to OVA plus IL-33 (day 
1). On days 21, 22, and 23, recipient mice were challenged i.n. with 100 μg OVA alone. 
Plasma was collected for analysis of specific antibodies on days 14, 24, and 49. In other 
experiments, similar cell populations were sorted and injected into Il7r−/ − mice at a 
concentration of 150,000 cells/mouse. The recipient mice were exposed to OVA plus IL-33 
on days 0, 3, and 6, and assessed for airway inflammation on day 8.
RESULTS
IL-33 promotes the development of two distinct subsets of IL-4-competent CD4+ T cells in 
draining lymph nodes
Respiratory exposure to innocuous proteins generally induces immune tolerance.17 Recently, 
airway epithelial cells that produce innate cytokines such as IL-1α, IL-25, IL-33, and thymic 
stromal lymphopoietin (TSLP), and that promote Th2-type immunity, were implicated in 
asthma and allergic diseases.18 Further, members of the IL-1 family of cytokines have been 
shown to overcome suppression by regulatory T cells (Tregs) and to promote functional 
differentiation of T cells.19
To better understand the mechanisms involved in the development of Th2-type immunity to 
airborne allergens, we exposed the airways of naïve BALB/c mice to endotoxin-free OVA 
with or without IL-1β or IL-33 twice via intranasal (i.n.) administration (Figure 1A). 
Subsequently, we examined the production of type 2 cytokines in draining mediastinal 
lymph nodes (mLNs) on day 11 and plasma antibody levels on day 14. As expected, 
exposure to OVA alone resulted in negligible plasma anti-OVA antibody levels (Figure 1B). 
Similarly, the i.n. administration of IL-1β or IL-33 alone did not have a remarkable effect on 
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anti-OVA antibody levels (data not shown). In contrast, when animals were exposed to OVA 
in conjunction with IL-1β, plasma levels of anti-OVA IgE and IgG1, another Ig isotype 
related to Th2-type immunity,20 increased significantly (p<0.01); however, no increases in 
the IgG2a isotype were observed. Likewise, the administration of OVA and IL-33 promoted 
the production of anti-OVA IgE and IgG1, but the levels were slightly lower than those 
induced by OVA plus IL-1β (p<0.05).
When cultured in vitro with OVA antigen, mLN cells from the mice exposed to OVA plus 
IL-1β produced IL-4 and IL-13, but only minimal IL-5 (Figure 1C). In contrast, mLN cells 
from the mice exposed to OVA plus IL-33 exhibited robust production of all three type 2 
cytokines. Further, the concentrations of IL-13 produced by mLN cells from mice exposed 
to OVA plus IL-33 were significantly higher than the corresponding IL-13 levels produced 
by mLN cells from mice exposed to OVA plus IL-1β (p<0.05). However, the IL-4 
concentrations produced by mLN cells from the mice exposed to OVA plus IL-33 and from 
mice exposed to OVA plus IL-1β were comparable. When mice previously exposed to OVA 
plus IL-33 were challenged i.n. with OVA alone, they developed marked airway eosinophilia 
and increased levels of IL-5 and IL-13 in bronchoalveolar lavage (BAL) fluids.21 In contrast, 
mice previously exposed to OVA plus IL-1β produced modest airway eosinophilia and lower 
BAL levels of IL-5 and IL-13.
These findings led us to hypothesize that two or more subsets of Th2-like CD4+ T cells with 
similar capacities to produce IL-4 but distinct IL-5 and IL-13 production might be involved. 
Th2 cells and Tfh cells are among the CD4+ T cells that are known to produce IL-4.11, 22 To 
characterize IL-4-producing cells, we exposed 4get IL-4-reporter mice23 i.n. to OVA plus 
IL-1β or IL-33 using the same protocol as described in Figure 1A, and analyzed mLN cells 
on day 11. In 4get mice, an internal ribosomal entry site (IRES) and downstream enhanced 
green fluorescent protein (eGFP) are inserted at the 3’ end of Il4, which allows the 
identification of cells that actively transcribe the IL-4 locus. Consequently, IL-4eGFP+ CD4+ 
T cells were clearly detectable in mLNs from mice exposed to OVA plus IL-1β or OVA plus 
IL-33 (Figure 1D and 1E).
The IL-33 receptor ST2 and the chemokine receptor CXCR5 are considered reliable markers 
for differentiated Th2 cells24 and early and mature Tfh cells,25 respectively. A majority 
(>80%) of CD4+IL-4eGFP+ cells in mLNs from mice exposed to OVA plus IL-1β were 
positive for CXCR5+ but were negative for ST2 (ST2−CXCR5+). In contrast, 
CD4+IL-4eGFP+ cells from the mice exposed to OVA plus IL-33 consisted of two distinct 
populations that included ST2−CXCR5+ cells and ST2+CXCR5− cells. Further, none of the 
IL-4eGFP+ cells were positive for both ST2 and CXCR5.
To characterize the development of these two subsets of IL-4-competent CD4+ T cells 
further, we examined the relationship between IL-33 dose and effect. Naïve mice were 
administered a fixed dose of OVA (100 μg) i.n. with various doses of IL-33. A small number 
of CD4+ T cells consisting of ST2−CXCR5+ cells were IL-4eGFP+ following administration 
of a low (1 ng) IL-33 dose (Figure 1F and 1G). Following the administration of an 
intermediate (10 ng) IL-33 dose, the number of IL-4eGFP+ cells increased, and a majority 
(~80%) of the cells were ST2−CXCR5+. However, the frequency of ST2+CXCR5− cells 
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relative to ST2−CXCR5+ cells increased significantly (p<0.01) following the administration 
of a higher (100 ng) IL-33 dose. Similarly, IL-33 at a range from 1 to 100 ng/dose induced 
production of anti-OVA IgE and IgG1 antibodies in a dose-dependent manner (Figure E1 of 
Online Repository). Kinetic studies showed that ST2−CXCR5+ cells were clearly detectable 
as early as 4 days after one exposure to OVA plus IL-33 (100 ng), while the development of 
ST2+CXCR5− cells required more time and/or a second exposure to OVA plus IL-33 (Figure 
E2 of Online Repository). Thus, the types and doses of IL-1 family cytokines influenced the 
differential development of two subsets of IL-4-competent CD4+ T cells in draining lymph 
nodes in the murine lung.
ST2-CXCR5+ CD4+ T cells are bona fide Tfh cells
To investigate the identity of the CD4+ T cell populations, we sorted 
IL-4eGFP+ST2-CXCR5+ and IL-4eGFP+ST2+CXCR5− cells harvested from mice exposed 
to OVA plus IL-33, and analyzed polyA-containing RNAs by microarray using a pool of 
IL-4eGFP-CD4+ T cells as the control. The comparison of gene expression profiles revealed 
sets of genes that were unique to each population and not expressed by other populations 
(Figure 2A and 2B). For example, ST2+CXCR5− cells expressed Th2 cell markers, 
including Gata3, Il5, Il13, and Prdm1 (encoding Blimp-1), as well as Il6, receptors for 
certain chemokines and lipid mediators, and integrins (Figure 2C). Conversely, the 
ST2-CXCR5+ cells expressed Tfh cell marker genes, including Bcl6, Pdcd1 [encoding 
programmed cell death protein 1 (PD-1)], and Sh2d1a [encoding signaling lymphocyte 
activation molecule (SLAM)-associated protein (SAP)], as well as a set of chemokine 
receptors and integrins that were distinct from those expressed by the ST2+CXCR5− cells. 
Tcf7 (encoding TCF-1), a recently identified upstream transcription factor for Tfh cells,26 
was expressed by ST2−CXCR5+ cells and IL-4eGFP− control cells. Il4 and Il21 were 
expressed by the ST2+CXCR5− and ST2−CXCR5+ cells, whereas Il5 and Il13 were 
expressed only by ST2+CXCR5− cells, which were verified by real-time quantitative reverse 
transcription polymerase chain reaction (qRT-PCR) (Figure 2D). As well, qRT-PCR analyses 
also revealed that Gata3 was most highly expressed by ST2+CXCR5− cells, whereas Bcl6 
was most highly expressed by ST2−CXCR5+ cells.
To examine cytokine production, CD4+ST2+CXCR5− and CD4+ST2−CXCR5+ T cells were 
isolated and cultured with OVA antigen and B cells from mLNs of sensitized mice, which 
served as antigen presenting cells (APCs; Figure 2E). We used the entire population of 
CD4+ T cells as the source for cell sorting, so that we could obtain sufficient cell numbers 
for culture (Figure E3 of Online Repository). Although the ST2+CXCR5− cells and 
ST2−CXCR5+ cells both exhibited robust production of IL-4, IL-5 was only produced by 
ST2+CXCR5− cells (Figure 2F). As well, a significantly higher amount of IL-13 was 
produced by ST2+CXCR5− cells than by ST2-CXCR5+ cells, but the reverse was the case 
for IL-21. Interestingly, when B cells isolated from the spleens of naïve mice were used as 
APCs, the ST2+CXCR5− cells produced IL-4 and IL-13, but the ST2−CXCR5+ cells did not 
(Figure E4 of Online Repository). From these observations, we concluded that 
IL-4eGFP+ST2+CXCR5− cells were canonical Th2 cells and that IL-4eGFP+ST2−CXCR5+ 
cells were Tfh cells specialized for the production of IL-4 and IL-21.
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Isolated Th2 cells and Tfh cells preferentially mediate allergic airway inflammation and IgE 
antibody production, respectively
The stimulation of B cells by IL-4, together with other signals, leads to class-switch 
recombination to IgE.20 Further, conventional models predict that Th2-type CD4+ T cells 
serve as a major source of IL-4 for B cell production of IgE antibody.3, 27 Therefore, to 
compare the capacity of Th2 and Tfh cells to mediate IgE antibody production, we chose an 
adoptive transfer approach. We isolated Th2 cells (CD4+ST2+CXCR5−) and Tfh cells 
(CD4+ST2−CXCR5+) from C57BL/6 mice previously exposed to OVA plus IL-33 and 
transferred them intravenously to naïve T cell-deficient Tcrb−/− mice (C57BL/6 background) 
with an intact B compartment28 (Figure 3A). In the absence of T transferred cells, Tcrb−/− 
mice were unable to produce detectable levels of anti-OVA IgE or IgG1 antibody (Figure 
3B). However, when Th2 cells from mice exposed i.n. to OVA plus IL-33 were transferred to 
Tcrb−/− mice, the mice produced anti-OVA IgE antibody, but the levels declined after day 
24. When Tfh cells were transferred to Tcrb−/− mice, the mice exhibited robust production of 
anti-OVA IgE antibody, and the levels were maintained up to at least day 49. IgG1 anti-OVA 
isotype antibody levels in the mice continued to rise following the transfer of either Th2 
cells or Tfh cells, but IgG2a antibody did not achieve detectable levels.
To compare the roles of Th2 and Tfh cells in airway inflammation, we used mice deficient in 
the IL-7 receptor alpha chain (Il7r−/−) (C57BL/6 background) as recipients (Figure 3C). 
IL-33 can activate innate immune cells, such as ILC2s, which makes it difficult to interpret 
the contributions of T cells to airway inflammation, but Il7r−/− mice lack ILCs.2 As 
expected, naïve Il7r−/− mice produced no detectable levels of cytokines when challenged i.n. 
with OVA plus IL-33 without the transfer of T cells. However, Il7r−/− mice that received Th2 
cells and were challenged i.n. with OVA plus IL-33 produced marked levels of type 2 
cytokines in bronchoalveolar lavage (BAL) fluids (Figure 3D) and developed profound 
airway eosinophilia (Figure 3E). Conversely, no inflammatory responses were observed in 
Il7r−/− mice that received Tfh cells.
To compare the anatomical location of Th2 cells and Tfh cells during type 2 immune 
responses, 4get mice previously exposed to OVA plus IL-33 were challenged i.n. with OVA 
antigen (Figure 4A). A large number of Th2 cells were localized in lung tissues and BAL 
fluids, and some were detectable in mLNs (Figure 4B and 4C). In contrast, Tfh cells 
remained in mLNs even after antigen challenge, whereas only a limited number were 
identified in lung tissues or BAL fluids. These findings suggested that Th2 cells were mobile 
and mediated type 2 cytokine production and inflammation in the airways. In contrast, the 
Tfh cells remained in the draining lymph nodes and likely contributed to the sustained 
production of IgE antibody.
Airway exposure to natural allergens induces Tfh and Th2 cells
The initial experiments employed IL-1 family cytokines as an adjuvant to induce the 
development and differentiation of CD4+ T cells; however, the doses of these cytokines 
might have exceeded those observed in a physiologic setting. IL-4-competent Tfh cells have 
been previously reported in mice infected with helminth parasites.11–13 Therefore, to 
examine the roles of Th2 and Tfh cells in allergic airway responses in a physiological 
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setting, we sought to use naturally occurring allergens implicated in human allergic airway 
diseases, including a fungus belonging to the genus Alternaria, the cockroach and house dust 
mite (HDM), and the cysteine protease bromelain as a generic model for protease 
allergens.29–31
Naïve 4get mice were exposed i.n. to allergen extracts twice without any adjuvants or 
exogenous cytokines (Figure 5A). IL-4-competent CD4+ T cells (IL-4eGFP+CD4+ T cells) 
were clearly detected in mLNs of mice exposed to these allergens (Figure 5B). Among the 
allergens tested, the Alternaria extract induced the largest numbers of IL-4eGFP+ cells 
(Figure 5C). Conversely, the cockroach extract yielded relatively small effects. A large 
proportion of IL-4eGFP+ cells (up to 55%) demonstrated an ST2−CXCR5+ phenotype 
(Figure 5B and 5C), which suggested that airway exposure of naïve mice to natural allergens 
triggered Tfh cell development. ST2+CXCR5− Th2 cells were also detected in mice exposed 
to Alternaria, HDM, or bromelain, but to a lesser extent than the detection of Tfh cells. 
Interestingly, bromelain induced a larger proportion of Th2 cells relative to Tfh cells, 
compared to the other allergen extracts, which suggested that the nature of the allergens 
affected the differential development of Tfh and Th2 cells.
Tfh cells are diminished by genetic depletion of Bcl6 in CD4+ T cells
Because the Alternaria extract induced the largest numbers of both Tfh and Th2 cells among 
the allergens, we selected Alternaria as a model for subsequent experiments aimed at 
defining the roles of these cell types in allergic immune responses. The transcriptional 
repressor BCL6 is considered the master regulator for the Tfh cell lineage.32, 33 However, 
germline Bcl6 knockout mice developed spontaneous inflammation, most likely due to the 
pro-inflammatory phenotype of Bcl6-deficient myeloid cells.34, 35
To investigate the specific roles of Tfh cells, we used a floxed Bcl6 mouse model in which 
Bcl6 was conditionally depleted in CD4+ T cells through the use of Cre recombinase 
expressed from the Cd4 promoter [Bcl6fl/flCd4-Cre mice14, 36]. These mice appeared 
normal, exhibited no apparent signs of disease (data not shown), and their thymus and spleen 
contained normal T cell numbers and CD4 and CD8 populations.14 We exposed 
Bcl6fl/flCd4-Cre mice i.n. to Alternaria extract spiked with 100 μg OVA (Figure 6A). OVA 
was included to allow us to monitor antigen-specific immune responses without relying on 
endogenous Alternaria proteins that are often unstable and are often present in variable 
concentrations in natural allergen extracts.37 When exposed to Alternaria plus OVA, Bcl6fl/fl 
mice lacking CD4-Cre developed both ST2+CXCR5− Th2 cells and ST2−CXCR5+ or 
PD-1+CXCR5+ double-positive Tfh cell populations (Figure 6B and 6C). Further, the Tfh 
cell population was abolished in Bcl6fl/flCd4-Cre mice, but the Th2 cell population was not 
affected. The heterozygous floxed Bcl6 mice (Bcl6fl/+Cd4-Cre) exhibited an intermediate 
phenotype, suggesting that Tfh development was dependent on the copy number of Bcl6. 
The frequencies of B220+ B cells within mLN lymphocytes were similar between Bcl6fl/fl 
mice and Bcl6fl/flCd4-Cre mice (Figure 6D and 6E). Nonetheless, a marked decrease in the 
frequency and the total number of FAS+PNA+ germinal center (GC) B cells was observed in 
Bcl6fl/flCd4-Cre mice.
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To examine whether the antigen-specific effector functions of Th2 cells were affected by 
Bcl6 deficiency, we restimulated mLN cells with the OVA antigen in vitro. Following 
stimulation with OVA, mLN cells from Bcl6fl/fl mice (no CD4-Cre) produced IL-4, IL-5, 
and IL-13 (Figure 6F). Conversely, Bcl6fl/flCd4-Cre mice displayed increased spontaneous 
production of these cytokines without antigen stimulation. Further, when stimulated with 
OVA, Bcl6fl/flCd4-Cre mice produced even greater amounts of IL-5 and IL-13 than Bcl6fl/fl 
mice. Thus, deletion of Bcl6 in CD4+ T cells resulted in striking decreases in both Tfh cells 
and GC B cells, but Th2 cell numbers were not affected. The data also suggested that the 
effector function of Th2 cells was enhanced in the absence of Bcl6.
Tfh cells are essential for the production of allergen-specific IgE antibodies
To investigate the roles of Tfh cells in allergic immune responses to inhaled allergens, 
Bcl6fl/flCd4-Cre mice and their littermate controls (Bc6fl/fl) were initially exposed i.n. to 
Alternaria extract with OVA, and then re-exposed i.n. to the OVA antigen alone (Figure 7A). 
As expected, Bcl6fl/fl mice that were only exposed to OVA did not develop antibodies at any 
time point (Figure 7B). When initially exposed to Alternaria extract plus OVA, Bcl6fl/fl mice 
developed anti-OVA IgE antibodies by day 14, which was sustained until at least day 35. In 
contrast, anti-OVA IgE antibodies were nearly undetectable in Bcl6fl/flCd4-Cre mice up to 
day 35 (p<0.01). Similarly, the plasma anti-OVA IgG1 levels continued to increase in 
Bcl6fl/fl mice, but were undetectable in Bcl6fl/flCd4-Cre mice. Further, the concentrations of 
total IgE and IgG1 in plasma were significantly reduced in Bcl6fl/flCd4-Cre mice compared 
to Bcl6fl/fl mice; however, no differences were observed in plasma concentrations of total 
IgA and IgM.
To examine the production of type 2 cytokines and inflammation in the respiratory mucosa, 
mice were re-exposed to OVA i.n. on days 42 through 44. Bcl6fl/fl mice that were previously 
exposed to OVA alone and subsequently re-exposed to OVA did not exhibit increases in type 
2 cytokines in the lung tissues (Figure 7C) or any signs of airway inflammation (Figure 7D). 
When initially exposed to Alternaria extract plus OVA and then re-exposed to OVA, Bcl6fl/fl 
mice displayed increased levels of IL-5 and IL-13 in the lungs and marked airway 
eosinophilia. Bcl6fl/flCd4-Cre mice also showed comparable increases in these cytokines and 
airway eosinophilia, which suggested that Tfh cells are required for IgE antibody 
production, but unnecessary for airway inflammation.
To verify this concept, we used a different genetic model. The interaction between inducible 
costimulator (ICOS) and the ICOS ligand (ICOSL) plays a critical role in Tfh cell 
differentiation.33, 38 Therefore, we subjected wild-type (WT) C57BL/6 mice or germline 
Icos-deficient mice (Icos−/−) to an experimental protocol that was similar to the one 
described above for Bcl6fl/flCd4-Cre mice (Figure E5A of Online Repository). Partial but 
significant decreases in ST2−CXCR5+ Tfh cells were observed in Icos−/− mice compared to 
WT mice (p<0.05, Figure E5B and E5C), but the number of ST2+CXCR5− Th2 cells was 
not affected. Further, when CD4+ T cells from Icos−/− mice were restimulated with OVA in 
vitro, the cells produced IL-5 and IL-13 (Figure E5D), and the cytokine levels were higher 
compared to those from WT mice. In contrast, the plasma levels of anti-OVA IgE and IgG1 
antibodies were markedly reduced in Icos−/− mice (Figure E5E).
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OX40L contributes to type 2 cytokine responses and airway inflammation but not to the 
development of Tfh cells or IgE antibody production
The prior observations led us to speculate that unlike a conventional model, the two key 
components of allergic immune responses, which are IgE antibody production and type 2 
cytokine responses, could be independently regulated by two subsets of IL-4-producing 
CD4+ T cells. To test this concept from a different angle, we sought a model in which the 
terminal differentiation of Th2 cells was impaired, but Tfh cells were unaffected.
OX40L, a tumor necrosis factor (TNF) family ligand that is the product of Tnfsf4, has been 
shown to play a role in the development of pathologic Th2 cells that are capable of 
mediating strong type 2 inflammatory responses in mice.39 When exposed i.n. to the 
Alternaria extract plus OVA, the numbers of ST2−CXCR5+ Tfh cells and ST2+CXCR5− Th2 
cells developed by mice lacking Tnfsf4 (Tnfsf4−/−) were comparable to WT C57BL/6 mice 
(Figure 8A and 8B). Nonetheless, the production of IL-4, IL-5, and IL-13 by T cells from 
Tnfsf4−/− mice was minimal following in vitro stimulation with OVA, which suggested that 
the effector functions of Th2 cells were impaired (Figure 8C; p<0.05). As well, when 
challenged with OVA in vivo (Figure 8D), Tnfsf4−/− mice displayed significantly lower 
levels of IL-4 and IL-13 in the lungs compared to WT mice (Figure 8E; p<0.05 and p<0.01, 
respectively), and airway eosinophilia was nearly abolished (Figure 8F). In contrast, 
Tnfsf4−/− mice developed robust anti-OVA IgE and IgG1 antibodies compared to 
corresponding levels observed in WT mice (Figure 8G).
DISCUSSION
In the current study, we exposed the airways of naïve mice to cytokines and natural allergens 
and examined the development of adaptive type 2 immune responses. A novel concept 
derived from this study was that two major components of allergic immune responses, IgE 
antibody production and type 2 cytokine responses, were regulated separately by Tfh and 
Th2 cells in vivo. The conventional model suggests that Th2-type CD4+ T cells play key 
roles in various features of allergic immune responses, including IgE antibody production, 
the production of type 2 cytokines, airway eosinophilia, and mucosal hyperplasia.3, 27 Our 
findings not only suggested that Tfh cells were necessary for IgE antibody production, but 
also that Tfh cells were sufficient even when canonical Th2 cells were absent or their 
effector functions were compromised. In contrast, Th2 cells played major roles in type 2 
cytokine production and eosinophilic airway inflammation even in the absence of Tfh cells 
or IgE antibodies, which suggested that Tfh cells and Th2 cells play distinct roles in allergic 
immune responses.
As shown in Figure 2, Th2 and Tfh cells were clearly distinguishable by their expression of 
key transcription factors and cell surface molecules, and by the production of IL-5, IL-13, 
and IL-21. Further, no overlap was detected between Th2 and Tfh cell populations when the 
phenotypes of IL-4eGFP+ cells were examined by fluorescence-activated cell sorting 
(FACS) using ST2 and CXCR5 as markers (Figure 1). Further, Th2 cells were mobilized to 
the lungs and airways during allergic immune responses, whereas Tfh cells remained in 
draining lymph nodes (Figure 4). These observations were consistent with an earlier study 
involving a Nippostrongylus brasiliensis infection model that demonstrated distinctive tissue 
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localization of Th2 cells (expressing both Il4 and Il13) and Tfh cells (expressing Il13 but not 
Il4).22 Therefore, the likelihood exists that allergic immune responses consist of two distinct 
subsets of IL-4-producing CD4+ T cells, each of which demonstrates unique phenotype, 
localization, and effector functions as summarized in Figure E6 of Online Repository. By the 
extension of this concept, it is tempting to speculate that certain human allergic diseases may 
involve Tfh cells rather than Th2 cells. Examples would be allergic diseases involving 
demonstrated roles for IgE antibodies and minimal signs of mucosal inflammation, such as 
food allergies and anaphylaxis.
IL-4-producing Tfh cells were previously described in mice infected with Leishmania major 
or various helminth parasites,11-13, 22 and in mice immunized systemically by injection of 
OVA plus alum.10 Our observations contributed to this knowledge by demonstrating that 
exposure of the airways of naïve BALB/c or C57BL/6 mice to natural allergens, such as 
Alternaria and HDM, induced IL-4-production by Tfh cells. Further, the proportions of Tfh 
and Th2 cells generated were dependent on the allergen. Nonetheless, questions remain 
regarding the immunological mechanisms involved in the development of Tfh cells 
following exposure to allergens. Previously, IL-6 and IL-21 were shown to induce Tfh cells 
in vitro. Specifically, CD4+ T cells cultured with IL-6 or IL-21 expressed BCL6 and/or 
CXCR5 mRNA in a STAT3-dependent manner.33, 40 However, the mechanisms of Tfh cell 
development in vivo appear to be rather complex. Il6−/−, Il21−/−, and Il21r−/− mice, as well 
as Stat3 deficient mice, exhibited no or minimal defects in Tfh cell development.41–43 
However, the blockage of IL-6 in Il21−/− mice and in Il6/Il21 double knockout mice resulted 
in a partial decrease in Tfh cells.44, 45
In this study, we found that the combined intranasal administration of IL-33 or IL- 1β and 
OVA effectively induced IL-4-competent Tfh cells, which suggested an alternative method 
for the generation of Tfh cells in vivo in the absence of infectious agents. However, mice 
lacking specific receptors, including IL-1R1 (receptor for IL-1α and IL-1β) or IL-1RL1 
(ST2, receptor for IL-33), developed levels of IgE antibody that were comparable to WT 
animals (data not shown). Hence, there appears to be considerable redundancy in the Tfh-
development pathway. This speculation is further supported by the observation that although 
only IL-33 effectively induced Th2 cells (Figure 1), Tfh cells were induced by either IL-33 
or IL-1β. Further, the concentration of IL-33 required to induce Tfh cells was approximately 
one-tenth or less the level needed for Th2 cell induction. The apparent redundancy and 
sensitivity in the system regarding the generation IL-4-producing Tfh cells, and the 
established extreme sensitivity of IgE- based recognition of allergens might have evolved to 
ensure the protection of the host against certain pathogens and avoidance of unfavorable 
environmental factors.46
At the molecular level, our mouse allergy models verified critical roles for BCL6 and ICOS 
in the development of Tfh cells in vivo. BCL6 is considered the master regulator for Tfh 
differentiation32, 33 because it inhibits the differentiation of other CD4+ T cell subsets 
through the repression of the transcription factor Blimp1.32 Germline Bcl6−/− mice develop 
spontaneous inflammatory diseases.34, 35 The use of Cd4-driven Cre recombinase in Bcl6-
floxed mice allowed us to determine that the deficiency of Bcl6 in the CD4+ T cell 
compartment resulted in nearly complete depletion of Tfh cells in vivo (Figure 6), but it did 
Kobayashi et al. Page 11
J Allergy Clin Immunol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
not induce systemic inflammation. The numbers of ST2-positive mature Th2 cells were not 
affected in these mice, but the production of type 2 cytokines was enhanced, which reflected 
the capacity of BCL6 to inhibit GATA3 expression and Th2 cell differentiation.47
ICOS has been shown to play an important role in the development and effector functions of 
Tfh cells and various other T cells subsets, including Th1, Th2, Th17, and Treg cells.48 Mice 
deficient in ICOS signaling consistently displayed decreased serum levels of IgE and 
IgG1.49–52 ICOS has also been shown to promote the expansion of Th2 cells,53, 54 which 
provides a potential mechanistic basis for decreased levels of IgE, but the results are 
controversial.50, 55 In this study, Icos−/− mice exhibited marked decreases in Tfh cells 
compared to WT mice when exposed to airborne allergens, which was consistent with 
previous findings.11, 33, 38 However, these mice paradoxically exhibited enhanced Th2-type 
cytokine responses. The differences in our results and some previous observations could be 
explained by differences in the models, including adjuvants used and routes of antigen 
administration. Nonetheless, ICOS signaling is critical for Bcl6 expression;38 thus, it was 
expected that ICOS deficiency could result in a phenocopy of Bcl6 deficiency in CD4+ T 
cells. Notwithstanding, BCL6 and ICOS likely served as a molecular switch and played a 
role in determining whether naïve CD4+ T cells differentiated into Tfh or Th2 cells.
It has been established that IL-4 and its downstream signaling molecules are required for the 
class-switch recombination of IgE antibody in vitro and in vivo.56 In our model, Tfh and 
Th2 cells from day 11 mLNs were both capable of producing IL-4 when they were 
restimulated with antigen in vitro, despite the fact that the Il4 regulatory mechanisms in Tfh 
and Th2 cells appear distinct.10, 22 We also found that the adoptive transfer of either Tfh or 
Th2 cells induced the production of IgE and IgG1 antibodies (Figure 3). Importantly, the 
production of IgE antibody induced by transfer of Tfh cells was sustained for at least 4 
weeks after the final antigenic stimulation; however, the IgE response induced by Th2 cells 
was relatively transient. Nonetheless, sustained increases in IgG1 antibody were observed 
following the transfer of either Tfh or Th2 cells. Previous studies involving the injection of 
mice with a goat antibody to mouse IgD indicated that T cell help exclusive of IL-4 
production was important for the generation of an IgE response, but not for an IgG1 
response.57 Hence, Tfh cells might provide signals other than IL-4 for optimized and 
sustained IgE production, perhaps through a direct physical interaction with B cells or the 
release of additional soluble factors. IL-21, which is abundantly produced by Tfh cells,9 
could be a candidate factor. Nonetheless, the roles of IL-21 in IgE antibody production are 
rather controversial. For example, IL-21 induced 58 or inhibited 59, 60 IgE antibody 
production in vitro. In an in vivo study, IL-21R-deficient mice produced even higher levels 
of IgE. 61 Alternatively, any molecules that are identified by microarray analyses as unique 
to Tfh cells (Figure 2), such as PD-1, SAP, B and T lymphocyte attenuator (BTLA), or a 
combination of these molecules, could play a comparable role. Accordingly, additional 
studies aimed at identifying critical molecule(s) provided by Tfh cells, which are involved in 
the sustained production of IgE antibodies during allergic immune responses, are required.
Given our observations, the robust and unique characteristics of Tfh cells in the mediation of 
IgE antibody production might explain the pathophysiology of various IgE-dependent 
allergic diseases, such as food allergies and anaphylaxis. Recognizing the involvement of 
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Tfh and Th2 cells, which are two distinct subsets of IL-4-producing CD4+ T cells (Figure E6 
of Online Repository), could aid in redefining the mechanisms involved in allergic diseases. 
Nonetheless, achieving a better understanding of the molecular and immunological 
mechanisms involved in the differentiation and functions of Tfh cells and methods to disrupt 
these pathways will be of central importance in the development of new treatment and 
preventive strategies for allergic diseases.
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Abbreviations
APCs antigen presenting cells
BAL bronchoalveolar lavage
BTLA B and T lymphocyte attenuator
eGFP enhanced green fluorescent protein
FACS fluorescence-activated cell sorting
GC germinal center
GWAS genome-wide association study
HDM house dust mite
ICOS inducible costimulatory
ICOSL ICOS ligand
IL interleukin
ILC2 type 2 innate lymphoid cells
i.n intranasal
i.p intraperitoneal
IRES internal ribosomal entry site
i.v intravenous
mLN mediastinal lymph node
LNs lymph nodes
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OVA ovalbumin
PD-1 programmed cell death protein 1
qRT-PCR quantitative reverse transcription polymerase chain reaction
SAP signaling lymphocyte activation molecule-associated protein
SNPs single nucleotide polymorphisms
SPF specific pathogen-free
Tfh follicular helper T
Th2 type 2 helper T
TNF tumor necrosis factor
Tregs regulatory T cells
TSLP thymic stromal lymphopoietin
WT wild-type
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Key Messages
• IL-4-producing Tfh cells develop when mice are exposed to airborne 
allergens.
• Allergen-specific Tfh cells and Th2 cells possess distinct 
characteristics.
• The Tfh cells are necessary and sufficient for IgE antibody production.
• Allergic immune responses involve two subsets of IL-4-producing 
CD4+ T cells.
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Figure 1. 
IL-33 promotes the development of two distinct subsets of IL-4-competent CD4+ T cells. 
(A) A schematic representation of a mouse airway sensitization model. Naïve 4get mice 
(BALB/c background) were exposed i.n. to OVA with or without IL-1β or IL-33. (B) On day 
14, plasma was analyzed for anti-OVA antibodies by ELISA. * = p<0.05 and ** = p<0.01 
compared to mice exposed to OVA alone. # = p<0.05 compared to mice exposed to OVA 
plus IL-33. Data are presented as the mean ± SEM (n = 4–5 in each group). (C) Day 11 
mLN cells were cultured with or without OVA. The cytokine levels in the supernatants were 
analyzed by ELISA. # = p<0.05 compared to OVA plus IL-33. Data are presented as the 
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mean ± SEM (n = 4–5 in each group). (D–G) Day 11 mLN cells were gated on lymphocytes, 
and the expression of CD4, IL-4eGFP, ST2, and CXCR5 was analyzed by FACS. (D) 
Representative scattergrams showing the expression of CD4 and IL-4eGFP in a total 
lymphocyte population, and the expression of ST2 and CXCR5 in CD4+IL-4eGFP+ 
lymphocytes. (E) Numbers of each cell population are presented as the mean ± SEM (n = 4 
in each group). * = p<0.05 between the groups indicated by horizontal lines. (F) Naïve 4get 
mice were exposed i.n. to OVA with different doses of IL-33 as described in Figure 1A, and 
day 11 mLN cells were analyzed. (G) Numbers and the ratio of each cell population are 
presented as the mean ± SEM (n = 4 in each group). ** = p<0.01 between the groups 
indicated by horizontal lines or as compared to 1 ng IL-33. (C, E, G) Data are a pool of two 
separate experiments.
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Figure 2. 
ST2-CXCR5+ CD4+ T cells are bona fide Tfh cells. (A–D) Naïve 4get mice (BALB/c 
background) were exposed i.n. to OVA plus IL-33 as described in Figure 1A. The cell 
populations indicated (CD4+IL-4eGFP−, CD4+IL-4eGFP+ST2+CXCR5−, and 
CD4+IL-4eGFP+ST2−CXCR5+) were sorted from day 11 mLN cells, and mRNA was 
analyzed by microarray and qRT-PCR. (A) The heat map shows microarray gene expression 
data (genes selected for fold difference >10) based on cells isolated from two separate 
experiments. (B) The Venn diagram shows the number of gene probes in each gene 
expression group. (C) Representative genes in each group are presented using the criteria 
described in the Table. (D) mRNA expression of select genes was analyzed by qRT-PCR, 
and the results were normalized to 18s RNA levels and expressed as a ratio to the 
CD4+IL-4eGFP− population (mean ± SEM, n = 4). * = p<0.05 and ** = p<0.01 between the 
groups indicated by horizontal lines. (E, F) Naïve BALB/c mice were exposed i.n. to OVA 
plus IL-33, as described in Figure 1A. Day 11 mLN cells were sorted into 
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CD3+CD4+ST2-CXCR5−, CD3+CD4+ST2+CXCR5−, and CD3+CD4+ST2−CXCR5+ cell 
populations and cultured with B cells isolated from mLNs in the presence of OVA. (F) 
Cytokine levels in the supernatants were analyzed by ELISA. Data are presented as the 
mean ± range from duplicate cultures. The figure is representative of two separate 
experiments.
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Figure 3. 
Th2 and Tfh cells preferentially mediate allergic airway inflammation and IgE antibody 
production, respectively. (A) A schematic representation of an adoptive transfer model to 
Tcrb−/− mice (C57BL/6 background) (B) The plasma antibody levels were analyzed by 
ELISA. Results are the mean ± SEM (n = 3 in each group). ** = p<0.01 compared to mice 
that received Th2 cells. (C) A schematic representation of an adoptive transfer model to 
Il7−/− mice (C57BL/6 background). BAL fluids were analyzed for cytokine levels (D) and 
inflammatory cell numbers (E). Results are the mean ± SEM (n = 3 in each group). ** = 
p<0.01 between the groups indicated by horizontal lines. (B, D, E) Each figure is 
representative of two separate experiments.
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Figure 4. 
Th2 and Tfh cells localize differently during allergic immune responses. (A) A schematic 
representation of a mouse airway sensitization and challenge model. (B) Representative 
scattergrams show the expression of ST2 and CXCR5 in the CD4+IL-4eGFP+ population. 
(C) Percentages of each cell population are presented as the mean ± SEM (n = 8 in each 
group). ** = p<0.01 between the groups indicated by horizontal lines. Data are a pool of two 
separate experiments.
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Figure 5. 
Airway exposure to natural allergens induces Tfh and Th2 cells. (A) A schematic 
representation of the airway allergen exposure model. Naïve 4get mice (BALB/c 
background) were exposed i.n. to allergen extracts without any adjuvants. Day 11 mLN cells 
were gated on lymphocytes, and the expression of CD4, IL-4eGFP, ST2, and CXCR5 was 
analyzed by FACS. (B) Representative scattergrams are shown. (C) Numbers of each cell 
population are presented as the mean ± SEM (n = 3 in each group). Data are representative 
of two separate experiments, except for HDM, where the experiment was performed only 
once.
Kobayashi et al. Page 25
J Allergy Clin Immunol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 6. 
Tfh cells are diminished by depletion of Bcl6 in CD4+ T cells
(A) A schematic representation of a mouse airway sensitization model. (B) Representative 
scattergrams show the expression of ST2, CXCR5, and PD-1 in the CD4+ T cell population. 
mLN cells were analyzed by gating on CD4+ T cells in the lymphocyte population. (C) Cell 
numbers in each cell population are presented as the mean ± SEM (n = 5–7 in each group). * 
= p<0.05 and ** = p<0.01 between the groups indicated by horizontal lines. Data are a pool 
of three separate experiments. (D, E) Expression of B220, PNA, and FAS in mLN 
lymphocytes was analyzed by FACS. (D) Representative scattergrams show the expression 
of B220 in the lymphocyte population and the expression of PNA and FAS in the B220+ cell 
population. (E) Percentages and cell numbers in each cell population are presented as the 
mean ± SEM (n = 4 in each group). * = p<0.05 and ** = p<0.01 between the groups 
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indicated by horizontal lines. (F) Day 11 mLN cells were cultured with or without OVA, and 
the cytokine levels in the supernatants were analyzed by ELISA. Results are shown as the 
mean ± SEM (n = 4 in each group). * = p<0.05 between the groups indicated by horizontal 
lines.
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Figure 7. 
Tfh cells are necessary for the production of allergen-specific IgE antibody. (A) A schematic 
representation of a mouse airway sensitization and challenge model. (B) Plasma levels of 
anti-OVA IgE and IgG1 antibodies and total IgE, IgG1, IgM, and IgA were analyzed by 
ELISA. ** = p<0.01 compared to Bcl6 fl/fl mice previously exposed to OVA alone. ## = 
p<0.01 compared to Bcl6 fl/fl mice previously exposed to Alternaria extract plus OVA. Data 
are presented as the mean ± SEM (n = 5 in each group). The cytokine levels in lung 
homogenates (C) and the numbers of inflammatory cells in BAL fluids (D) were analyzed 
on day 45. (C, D) Results are presented as the mean ± SEM (n = 5 in each group). * = 
p<0.05 and ** = p<0.01 between the groups indicated by horizontal lines. Data are 
representative of two separate experiments.
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Figure 8. 
OX40L contributes to type 2 cytokine responses and airway inflammation but does not affect 
the development of Tfh cells or IgE antibody production. (A–C) Naïve C57BL/6 (WT) and 
OX40L knockout (Tnfsf4−/−) mice were exposed i.n. to OVA and Alternaria extract on days 
0 and 7, and mLN cells were analyzed on day 11. (A) Representative scattergrams show the 
expression of ST2 and CXCR5 in the CD4+ T cell population. (B) Numbers of each cell 
population are presented as the mean ± SEM (n = 4 in each group). (C) mLN cells were 
cultured with or without OVA, and the cytokine levels in the supernatants were analyzed by 
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ELISA. Results are the mean ± SEM (n = 5–7 in each group). * = p<0.05 between the 
groups indicated by horizontal lines. Data are representative of two separate experiments. 
(D) A schematic representation of a mouse airway sensitization and challenge model. The 
cytokine levels in lung homogenates (E) and the numbers of inflammatory cells in BAL 
fluids (F) were analyzed on day 25. Results are the mean ± SEM (n=5–7 in each group). * = 
p<0.05 and ** = p<0.01 between the groups indicated by the horizontal lines. (G) Plasma 
levels of anti-OVA IgE, IgG1, and IgG2a antibodies were analyzed by ELISA. * = p<0.05 
and ** p<0.01 between the groups indicated by horizontal lines. Data are presented as the 
mean ± SEM (n = 5–7 in each group). (C, E, F, G) Data are a pool of two separate 
experiments.
Kobayashi et al. Page 30
J Allergy Clin Immunol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
